June 8 (Reuters) – Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. (Reporting by Puyaan Singh in Bengaluru;
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
CNG and LNG penetration in CV industry projected to reach 30-35% by FY30: ICRA
New Delhi [India], July 27 (ANI): CNG and LNG penetration in the commercial vehicles (CV)…
Jordanian army says it downed two drones without material damage
July 27 (Reuters) - Jordan's armed forces said they intercepted and downed two drones on…
South Korea's Naver jumps 10% on Nvidia's $1 billion investment plan
SEOUL, July 27 (Reuters) - Shares of South Korean internet and cloud service giant Naver…
